Artimplant Interim Report January 1 - March 31, 2007
VASTRA FROLUNDA, Sweden--(BUSINESS WIRE)--
Net revenue of SEK 3.9 million (1.1)(a)
Net loss of SEK 2.9 million (10.4)
Earnings per share of SEK -0.05 (SEK -0.17)
Strong sales increase for Artelon® CMC Spacer – around 1,300 (400) units were sold to end-customers during Q1 2007
More than 4,000 patients had been treated with Artelon® devices through to Q1 2007